Citadel Advisors’s CollPlant Biotechnologies OPHI Stock Holding History
Bought
Maintained
Sold
Other funds holding OPHI
Citadel Advisors's OPHI Position: Q3 2026 in Review
Citadel Advisors sold out of CollPlant Biotechnologies (OPHI) in Q3 2026, closing a stake of 5,370 shares — an estimated $18.7K sold.
Citadel Advisors first reported a position in OPHI in Q3 2018 and held it in 9 quarters. The position peaked at $276K in Q2 2021. 8 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.
- Citadel Advisors reported no remaining CollPlant Biotechnologies position as of Q3 2026 after selling out during the quarter.
- Citadel Advisors sold 5,370 CollPlant Biotechnologies shares in Q3 2026, an estimated $18.7K.
- Citadel Advisors first reported a position in CollPlant Biotechnologies in Q3 2018 and held it in 9 quarters.
- Citadel Advisors's CollPlant Biotechnologies position peaked at $276K in Q2 2021.
- 8 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.